NRX Pharmaceuticals, Inc. (NRXP)
2.705
+0.12
(+4.44%)
USD |
NASDAQ |
Oct 15, 16:00
2.705
0.00 (0.00%)
After-Hours: 16:42
NRX Pharmaceuticals Net Income (Quarterly) : -16.52M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.52M |
| March 31, 2026 | -1.43M |
| December 31, 2025 | 0.36M |
| September 30, 2025 | -5.89M |
| June 30, 2025 | -17.58M |
| March 31, 2025 | -5.512M |
| December 31, 2024 | -9.078M |
| September 30, 2024 | -1.623M |
| June 30, 2024 | -7.897M |
| March 31, 2024 | -6.528M |
| December 31, 2023 | -4.332M |
| September 30, 2023 | -6.062M |
| June 30, 2023 | -8.717M |
| March 31, 2023 | -11.04M |
| December 31, 2022 | -10.24M |
| September 30, 2022 | -9.083M |
| June 30, 2022 | -6.982M |
| March 31, 2022 | -13.45M |
| Date | Value |
|---|---|
| December 31, 2021 | -30.79M |
| September 30, 2021 | -37.05M |
| June 30, 2021 | -0.1176M |
| March 31, 2021 | -25.49M |
| December 31, 2020 | -45.13M |
| September 30, 2020 | -5.162M |
| June 30, 2020 | 0.1023M |
| March 31, 2020 | 0.2732M |
| December 31, 2019 | -0.0148M |
| September 30, 2019 | 0.0592M |
| June 30, 2019 | 0.176M |
| March 31, 2019 | 0.188M |
| December 31, 2018 | 0.0291M |
| September 30, 2018 | 0.0281M |
| June 30, 2018 | -0.0066M |
| March 31, 2018 | 0.0155M |
| December 31, 2017 | -0.1038M |
| September 30, 2017 | -0.0012M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 210.00M |
| Eli Lilly & Co. | 7.095B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.101M |
| Total Expenses (Quarterly) | 17.62M |
| EPS Diluted (Quarterly) | -0.4388 |
| Enterprise Value | 86.34M |
| Gross Profit Margin (Quarterly) | 23.43% |
| Profit Margin (Quarterly) | -1.50K% |
| Earnings Yield | -27.23% |
| Normalized Earnings Yield | -19.64 |